사이트맵 보기

HANCOM IR

  • HANCOM
  • HANCOM WITH
  • HANCOM LIFECARE

Consolidated Statements of Financial Position

(KRW, Millions)
2023 2022 2021
Current assets 288,442 313,628 360,807
Non-current assets 343,337 381,260 485,857
Total assets 631,779 694,887 846,664
Current liabilities 104,043 162,891 203,912
Non-current liabilities 57,157 51,031 93,035
Total liabilities 161,199 213,922 296,947
Controlling interests 335,003 315,686 277,911
Non-controlling interests 135,577 165,279 271,806
Total equity 470,580 480,965 549,717

Consolidated Statements of Financial Position

(KRW, Millions)
2023 2022 2021
Sales 271,100 242,008 241,730
Operating profit 34,150 25,023 39,593
Continued operating profit -27,497 -21,705 9,500
Profit from discontinued operations - 38,414 -5,129
Net income -27,497 16,709 4,371
Controlling interests 15,081 46,757 18,007
Non-controlling interests -42,578 -30,048 -13,636
Other comprehensive Income -2,193 755 -290
Total Comprehensive Income -29,690 17,463 4,081

* The company sold MDS Tech (formerly Hancom MDS) and its subsidiaries in 2022, and has reflected discontinued operations in the financial statements for the 33rd and 32nd fiscal years(2021 & 2022).

Consolidated Statements of Financial Position

(KRW, Millions)
2023 2022 2021
Current assets 28,540 45,603 45,714
Non-current assets 185,275 179,344 176,302
Total assets 213,816 224,947 222,016
Current liabilities 68,110 78,866 64,333
Non-current liabilities 1,193 2,144 18,292
Total liabilities 69,302 81,010 82,625
Controlling interests 141,540 141,216 136,797
Non-controlling interests 2,974 2,721 2,594
Total equity 144,513 143,938 139,391

Consolidated Statements of Comprehensive Income

(KRW, Millions)
2023 2022 2021
Sales 410,145 28,706 26,233
Operating profit -2,463 -689 -155
Continued operating profit -5,499 4,207 3,011
Profit from discontinued operations 4,953 1,871 2,451
Net income -546 6,078 5,462
Controlling interests 900 6,806 5,171
Non-controlling interests -1,446 -728 291
Other comprehensive Income -770 -2,522 -97
Total Comprehensive Income -1,317 3,556 5,366

* On January 5, 2023, the Company spun off the Forensic Business Unit and subsequently sold 100% of the shares of the newly established company on March 2, 2023.
Accordingly, the financial statements for Q1 of FY25, FY24, and FY23(2021, 2022, and 2023 1Q) have been prepared to reflect discontinued operations.

Consolidated Statements of Financial Position

(KRW, Millions)
2023 2022 2021
Current assets 104,063 114,255 111,183
Non-current assets 78,147 93,774 102,944
Total assets 182,210 208,030 214,127
Current liabilities 53,330 76,537 92,759
Non-current liabilities 553 3,562 4,550
Total liabilities 53,883 80,100 97,309
Controlling interests 127,562 127,195 116,818
Non-controlling interests 765 736
Total equity 128,327 127,930 116,818

Consolidated Statements of Comprehensive Income

(KRW, Millions)
2023 2022 2021
Sales 112,780 100,120 121,140
Operating profit 1,832 -1,332 4,787
Net income 871 9,269 4,835
Controlling interests 825 9,204 2,835
Non-controlling interests 46 65
Other comprehensive Income -486 1,056 -819
Total Comprehensive Income 385 10,325 4,016